Nicholas Skipitaris, MD
Clinical Cardiac Electrophysiology · New York, NYNPI 1255355244
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $204,175 of the $293,164 with a category attached, or 69.6%. 23 manufacturers reported payments, led by Philips North America LLC at 50.8% of the total. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $803.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$149K
- Medtronic$50K
- Biotronik Inc.$31K
- Braemar Manufacturing, LLC$20K
- Boston Scientific$13K
- Sanofi-aventis U.S. LLC$8K
- plus $22K from 17 others
Across 14 payments — averaging $6765.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$95K
What the payments were for
- Consulting fees$204,17570%
- Speaking & faculty fees$48,70017%
- Travel & lodging$24,9239%
- Food & beverage$15,0085%
- Education$3590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 12 | $148,986 |
| Medtronic(2 entities) | 161 | $49,638 |
| Biotronik Inc. | 65 | $30,904 |
| Braemar Manufacturing, LLC | 1 | $20,000 |
| Boston Scientific | 27 | $13,069 |
| Sanofi-aventis U.S. LLC | 3 | $8,278 |
| Tri-anim Health Services, Inc. | 2 | $6,000 |
| Abbott | 55 | $5,617 |
| GE HealthCare | 9 | $5,475 |
| Irhythm Technologies, Inc. | 4 | $2,788 |
| Cardio Partners, Inc. | 1 | $800 |
| Impulse Dynamics (USA) Inc. | 4 | $322 |
| Biosense Webster, Inc. | 2 | $234 |
| Catheter Precision Inc. | 2 | $201 |
| Edwards Lifesciences | 2 | $197 |
| Volta Medical Inc | 2 | $172 |
| Baxter Healthcare | 4 | $149 |
| Vivaquant Inc, Dba Rhythm Express | 2 | $105 |
| Cardiva Medical, Inc. | 3 | $102 |
| Atricure, Inc. | 1 | $58 |
| Vital Connect, Inc | 1 | $27 |
| Johnson & Johnson | 1 | $24 |
| Elutia, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (5046) Holter$60,000
- (7999) SRC Undivided$34,290
- (5091) Amb Mon & Diag Und$30,000
- Ambulatory Monitoring & Diagnostics Undivided$22,500
- Cardiac Monitoring Suite$20,000
- ARCTIC FRONT ADVANCE$8,719
- Arctic Front$5,299
- GENERAL EP$4,892
- MULTAQ$3,978
- ZIO Patch$2,758
- IGT D Peripheral$2,000
- AVEIR$1,974
- CENTRICITY$1,769
- Edora$1,529
- Rivacor$1,529
- Acticor$1,529
- Sentus$1,200
- Plexa$1,200
- DiamondTemp$1,017
- AMPLATZER AMULET$957
How this compares
$293,164 in reported general payments places this provider in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 127 | $105,205 |
| XareltoRivaroxaban | 16 | $26,448 |
| Metoprolol Succinate | 54 | $934 |
| Amiodarone Hcl | 39 | $435 |
| Atorvastatin Calcium | 16 | $198 |
| Amlodipine Besylate | 13 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $24 | $26,44816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.
Other clinical cardiac electrophysiology in New York
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- James IpNew York$347K
- Mohit TuragamNew York$202K
- David LauNew York$202K
- Christopher LiuNew York$181K
- Chirag BarbhaiyaNew York$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.